Company: BIVIW
Filing Date: 2025-08-08
Form Type: 424B5
Source: 0001520138-25-000247
Chunk: 74

Company: BIOVIE INC.
Filing Date: 2025-08-08
Form: 424B5
Chunk 74
---
.001 par value; 10,000,000 shares authorized; 0 shares issued and outstanding                                                                      |     |        |            - |   |     |             |            - |   |
| Common stock, $0.0001 par value; 800,000,000 shares authorized at March 31, 2025; 1,854,574 shares issued of which 1,851,738 shares are outstanding at March 31, 2025 |     |        |        7,463 |   |     |             |        8,063 |   |
| Additional                                                                                                                                                            
 paid-in capital                                                                                                                                                       |     |        |  370,465,616 |   |     |             |  381,175,016 |   |
| Accumulated deficit                                                                                                                                                   |     |        | (348,655,105 | ) |     |             | (348,655,105 | ) |
| Treasury stock                                                                                                                                                        |     |        |          (29 | ) |     |             |          (29 | ) |
| Total stockholders’ equity                                                                                                                                            |     | $      |   21,817,945 |   |     |             |   32,527,945 |   |
| Total capitalization                                                                                                                                                  |     | $      |   24,660,215 |   |     |             |   35,370,215 |   |

The number of shares of our
Common Stock to be outstanding after this offering is based on 1,851,738 shares of our Common Stock outstanding as of March 31, 2025,
and excludes:

| · | 88,713 shares of our Common Stock issuable upon the exercise of outstanding 
 stock options at a weighted average exercise price of $294.70 per share;    |

| · | 960,056 shares of our Common Stock issuable upon the exercise of outstanding 
 warrants at a weighted average exercise price of $35.00 per share; and       |

| · | 11,054 shares of our Common Stock issuable upon vesting of restricted 
 stock units issued under our equity incentive plan.                   |

<div align='center'>39

Dilution</div>

If you invest in shares of our Common Stock in
this offering, your interest will be diluted to the extent of the difference between the public offering price per share of Common Stock
and the net tangible book value per share of Common Stock immediately after this offering.

The net tangible book value